Partner in Demarest's Life Sciences and Healthcare practice area, Elysangela Rabelo holds a specialization degree in Business Management from Business School São Paulo and a bachelor’s degree in Law from Universidade São Judas Tadeu. She has extensive experience in foreign investments, mergers and acquisitions, contracts, and regulatory affairs in these sectors. Elysangela represented domestic and international clients in different-sized projects, such as selling specialized medical clinics to strategic investors, advising a medical equipment multinational company in a public-private partnership within the hospital sector, selling private hospitals, purchasing pharmaceutical plants, and assisting in multi-jurisdictional transactions involving the purchase and sale of assets within the pharmaceutical industry. She was a pioneering professional in establishing the Life Sciences practice area in Brazil, combining M&A, commercial transactions, and regulatory affairs. Elysangela has been recognized by some of the main legal publications such as Chambers, Lexology, The Legal 500, and Análise Advocacia.
- Advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on a due diligence operation to purchase DiaSys Brazilian subsidiary.
- Advised Sanfre Farma on the acquisition of assets involving Flagyl product, of Sanofi-Medley Farmacêutica Ltda.
- Advised GSH Corp Participações S.A. in constituting a joint venture in the radiopharmaceuticals sector jointly with Telix Innovations S.A.
- Advised Virtue Diagnostics Cayman Limited on the acquisition of Labtest Laboratórios.
- Advised Medfar Centro de Manipulação de Fármacos Ltda. on the acquisition of Vella Empreendimentos e Participações Ltda, IPC – Instituto Paulista de Cancerologia Ltda., and Core – Clínica de Onco-Radioterapia Especializada Ltda.
- Specialization degree in Business Management from Business School São Paulo, São Paulo, Brazil (2007)
- Bachelor of Laws from Universidade São Judas Tadeu, São Paulo, Brazil (1998)
- Vice Chair of the Life Sciences Subcommittee integrating the IBA's Technology Law Committee
- Portuguese, English, and Spanish
- Coordinator of the article “Interoperability in healthcare: the state of affairs in Latin America”, International Bar Association, 2024
- Co-author of the article [Entre a norma e a prática: Resolução do CFM regulamenta o ato médico e traz implicações para demais profissões de saúde] “Between regulation and practice: CFM resolution regulates the medical practice with an impact on other health professionals”, JOTA, 2024.
- Co-author of the article [Perspectivas sobre a PEC do Plasma no Brasil: Entidades se posicionaram contra comercialização de plasma; PEC 10/22 aguarda votação no plenário do Senado] “Perspectives regarding the Plasma PEC in Brazil: Entities are against the commercialization of plasma; PEC 10/22 awaits voting in Senate plenary”, JOTA, 2024.
- Co-author of the article [Publicidade médica e o poder das mídias sociais na evolução do conceito de ética: Resolução adota abordagem mais realista e contemporânea em relação ao direito de divulgação por parte dos médicos] “Medical advertising and the power of social media in the evolution of the concept of ethics: Resolution adopts a more realistic and contzcemporary approach to the right of disclosure by physicians”, JOTA, 2023.
- Co-author of the article [Coisa julgada e seus possíveis impactos em operações de M&A: Além de afetar contratos já firmados, é importante destacar os efeitos nos contratos que serão firmados daqui para frente] “Res judicata and its possible impacts on M&A operations: In addition to affecting contracts executed, it is important to highlight the effects on contracts to be executed from now”, JOTA, 2023.
